Adial Pharmaceuticals, Inc
Symbol: ADIL (NASDAQ)
0.35
0.00 0.000
Company Description:
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
Key Stats
- Today's Open: $0.3526
- Today's High: $0.359
- Today's Low: $0.348
- Today's Volume: 211.71K
- Yesterday Close: $0.35
- Yesterday High: $0.359
- Yesterday Low: $0.3463
- Yesterday Volume: 303.29K
- Last Min Volume: 28
- Last Min High: $0.35
- Last Min Low: $0.35
- Last Min VWAP: $0.35
Company Profile
- Name: Adial Pharmaceuticals, Inc
- Website: https://www.adialpharma.com
- Listed Date: 2018-07-27
- Location: CHARLOTTESVILLE, VA
- Market Status: Active
- CIK Number: 0001513525
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $7.64M
- Round Lot: 100
- Outstanding Shares: 21.83M
- Asset Type: CS
RECENT FILINGS FOR ADIL
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-09 | S-8 | View |
| 2025-09-03 | 8-K | View |
| 2025-08-14 | 8-K | View |
| 2025-08-13 | 10-Q | View |
| 2025-08-01 | 424B5 | View |
| 2025-08-01 | 8-K | View |
| 2025-08-01 | 8-K | View |
| 2025-07-31 | 424B5 | View |
| 2025-07-16 | 8-K | View |
| 2025-07-10 | 8-K | View |
| 2025-06-27 | DEFR14A | View |
| 2025-06-23 | SCHEDULE 13G | View |
| 2025-06-18 | 8-K | View |
| 2025-06-18 | 424B5 | View |
| 2025-06-17 | PRER14A | View |
| 2025-06-16 | EFFECT | View |
| 2025-06-16 | 8-K | View |
| 2025-06-13 | S-1/A | View |
| 2025-06-12 | CORRESP | View |
| 2025-06-12 | CORRESP | View |
Latest News on ADIL